Pacifichealth Laboratories Stock Beta
| PHLIDelisted Stock | USD 0.0001 0.00 0.00% |
PacificHealth Laboratories fundamentals help investors to digest information that contributes to PacificHealth Laboratories' financial success or failures. It also enables traders to predict the movement of PacificHealth Pink Sheet. The fundamental analysis module provides a way to measure PacificHealth Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PacificHealth Laboratories pink sheet.
PacificHealth |
PacificHealth Laboratories Company Beta Analysis
PacificHealth Laboratories' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current PacificHealth Laboratories Beta | -275.06 |
Most of PacificHealth Laboratories' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PacificHealth Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
CompetitionIn accordance with the recently published financial statements, PacificHealth Laboratories has a Beta of -275.0558. This is 22462.26% lower than that of the Personal Products sector and notably lower than that of the Consumer Staples industry. The beta for all United States stocks is notably higher than that of the company.
PacificHealth Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PacificHealth Laboratories' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of PacificHealth Laboratories could also be used in its relative valuation, which is a method of valuing PacificHealth Laboratories by comparing valuation metrics of similar companies.PacificHealth Laboratories is currently under evaluation in beta category among its peers.
As returns on the market increase, returns on owning PacificHealth Laboratories are expected to decrease by larger amounts. On the other hand, during market turmoil, PacificHealth Laboratories is expected to outperform it.
PacificHealth Fundamentals
| Return On Equity | -0.75 | ||||
| Return On Asset | -0.25 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | (0.14) % | ||||
| Current Valuation | 571.89 K | ||||
| Shares Outstanding | 20.87 M | ||||
| Price To Earning | (0.34) X | ||||
| Price To Book | 0.71 X | ||||
| Price To Sales | 0.07 X | ||||
| Revenue | 6.91 M | ||||
| Gross Profit | 2.99 M | ||||
| EBITDA | (861.23 K) | ||||
| Net Income | (486.31 K) | ||||
| Cash And Equivalents | 324.48 K | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 54.86 K | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 1.58 X | ||||
| Book Value Per Share | 0.04 X | ||||
| Cash Flow From Operations | (503.96 K) | ||||
| Earnings Per Share | (0.04) X | ||||
| Target Price | 2.8 | ||||
| Beta | -275.06 | ||||
| Market Capitalization | 87 | ||||
| Total Asset | 1.89 M | ||||
| Retained Earnings | (20.59 M) | ||||
| Working Capital | 676 K | ||||
| Current Asset | 1.84 M | ||||
| Current Liabilities | 1.17 M | ||||
| Z Score | -11.0 | ||||
| Net Asset | 1.89 M |
About PacificHealth Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PacificHealth Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PacificHealth Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PacificHealth Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in PacificHealth Pink Sheet
If you are still planning to invest in PacificHealth Laboratories check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PacificHealth Laboratories' history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |